Distribution agreement for peptide synthesis reagents

Published: 26-Apr-2017

Gyros Protein Technologies signs exclusive distribution of PurePep coupling agents in North America with Luxembourg Bio Technologies

Gyros Protein Technologies, automated nanoliter-scale immunoassays, peptide synthesisers and reagents supplier, has signed an exclusive distribution agreement with Luxembourg Bio Technologies.

The agreement is for two of the latter company's coupling agents, PyOxim and K-Oxyma, as well as HDMA, on a non-exclusive basis. Gyros Protein Technologies will sell these reagents as part of its PurePep brand.

Under the terms of the agreement, Gyros Protein Technologies has the exclusive rights to promote and sell these PurePep products to researchers in North America, and globally on a non-exclusive basis.

The addition of the PurePep Coupling Agents to Gyros Protein Technologies’ offering further enables researchers to efficiently synthesise simple to complex peptides, by increasing coupling efficiency and reducing racemisation.

All chemicals are 100% QC tested to deliver consistently high peptide purity and yield. The suite of PurePep Coupling reagents is available in standard and custom pack sizes.

Synthesiser platforms

Gyros Protein Technologies’ peptide synthesiser platforms are used in conjunction with PurePep reagents, which include bulk and pre-packed amino acids, resins, coupling agents and solvents.

Peptide synthesis optimisation using these reagents minimises downtime caused by clogging that can result from using impure and unstable reagents.

The platforms ensure that peptides are synthesised correctly the first time, with consistent quality and reduced synthesis variability.

You may also like